DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 5 USDMF, 1 EU WC, 1 KDMF, 4 NDC API, 8 Listed Suppliers

10 API Suppliers
5 USDMF
1 EU WC
1 KDMF
4 NDC API
8 Listed Suppliers

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 1 FDA Orange Book, 1 Europe, 1 Canada

3 FDF Dossiers
1 FDA Orange Book
1 Europe
1 Canada

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 26 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
26 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Finished Drug Prices

globalSalesInformation
1 US Medicaid Prescriptions
1 Finished Drug Prices

MARKET PLACE

1 APIs

marketPlace
1 APIs

PATENTS & EXCLUSIVITIES

63 US Patents, 1 US Exclusivities

patents
63 US Patents
1 US Exclusivities

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

26,798,625

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Migalastat hcl, 75172-81-5, Deoxygalactonojirimycin hydrochloride, Galafold, 1-deoxygalactonojirimycin hydrochloride, Amigal

Molecular Formula

C₆H₁₄ClNO₄

Molecular Weight

199.63 g/mol

InChI Key

ZJIHMALTJRDNQI-OLALXQGDSA-N

FDA UNII

CLY7M0XD20

1 2D Structure

Migalastat

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride

2.1.2 InChI

InChI=1S/C6H13NO4.ClH/c8-2-3-5(10)6(11)4(9)1-7-3;/h3-11H,1-2H2;1H/t3-,4+,5+,6-;/m1./s1

2.1.3 InChI Key

ZJIHMALTJRDNQI-OLALXQGDSA-N

2.1.4 Canonical SMILES

C1C(C(C(C(N1)CO)O)O)O.Cl

2.1.5 Isomeric SMILES

C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O.Cl

2.2 Other Identifiers

2.2.1 UNII

CLY7M0XD20

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 1-butyl-2-(hydroxylmethyl)piperidine-3,4,5-triol

2. 1-deoxy-galactonojirimycin

3. 1-deoxygalacto-nojirimycin

4. 1-deoxygalactonojirimycin

5. At1001 Deoxyjirimycin

6. Galafold

7. Gr181413a

8. Lucerastat

9. Migalastat

10. Migalastat Hcl

11. N-butyldeoxygalacto-nojirimycin

12. N-butyldeoxygalactonojirimycin

13. Nb-dgj

2.3.2 Depositor-Supplied Synonyms

1. Migalastat Hcl

2. 75172-81-5

3. Deoxygalactonojirimycin Hydrochloride

4. Galafold

5. 1-deoxygalactonojirimycin Hydrochloride

6. Amigal

7. Migalastat Hydrochloride [usan]

8. Migalastat (hydrochloride)

9. Cly7m0xd20

10. 75172-81-5 (hcl)

11. At-1001 (migalastat Hydrochloride)

12. (2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol Hydrochloride

13. (2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol Hydrochloride.

14. Gr181413a

15. Unii-cly7m0xd20

16. Migalastathcl

17. Galafold (tn)

18. Deoxygalactonojirimycin,hydrochloride

19. Deoxygalactonojirimycin, Hydrochloride

20. 1-deoxygalactonojirimycin Hcl

21. Schembl3802618

22. Chembl2107355

23. Dtxsid801026249

24. (+)-migalastat Hydrochloride

25. Hy-14929a

26. Mfcd00269962

27. Migalastat Hydrochloride (jan/usan)

28. Migalastat Hydrochloride [mi]

29. Migalastat Hydrochloride [jan]

30. 3,4,5-piperidinetriol, 2-(hydroxymethyl)-, Hydrochloride, (2r,3s,4r,5s)-

31. At13690

32. Cs-6380

33. Migalastat Hydrochloride [who-dd]

34. Migalastat Hydrochloride [orange Book]

35. D05031

36. 1,5-dideoxy-1,5-imino-d-galactitol Hydrochloride

37. W-203722

38. Q27275527

39. (+)-(2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol Hydrochloride

40. (2r,3s,4r,5s)-2-(hydroxymethyl)-3,4,5-piperidinetriol Hydrochloride

41. (2r,3s,4r,5s)-2-(hydroxymethyl)piperidine-3,4,5-triol;hydrochloride

42. 3,4,5-piperidinetriol, 2-(hydroxymethyl)-, Hydrochloride (1:1), (2r,3s,4r,5s)-

43. 3,4,5-piperidinetriol, 2-(hydroxymethyl)-, Hydrochloride,[2r-(2a,3a,4a,5b)]-

2.4 Create Date

2006-10-26

3 Chemical and Physical Properties

Molecular Formula	C₆H₁₄ClNO₄
Molecular Weight	199.63 g/mol
Hydrogen Bond Donor Count	6
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	1
Exact Mass	199.0611356 g/mol
Monoisotopic Mass	199.0611356 g/mol
Topological Polar Surface Area	93 Å²
Heavy Atom Count	12
Formal Charge	0
Complexity	132
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Indication

Galafold is indicated for long-term treatment of adults and adolescents aged 16 years and older with a confirmed diagnosis of Fabry disease (-galactosidase A deficiency) and who have an amenable mutation.

5 Pharmacology and Biochemistry

5.1 ATC Code

A16AX

API SUPPLIERS